Table 1 Patient characteristics and cardiac volumes measured from CMR

Age, years

67 [8]

70 [7]

0.822

65 [2]

0.103

Male, n (%)

11 (73)

5 (71)

1.0

4 (50%)

0.384

BMI > 30 kg/m², n (%)

1 (7)

2 (29)

0.227

0

–

QRS > 150 ms, n (%)

14 (93)

5 (71)

0.227

0

–

IHD etiology, n (%)

6 (40)

6 (86)

0.074

0

–

DCM etiology, n (%)

9 (60)

1 (14)

0.074

0

–

Previous myocardial infarction, n (%)

4 (27)

5 (71)

0.074

0

–

Heart-failure related hospitalization within 5 years, n (%)

2 (13)

0

1

0

–

Mortality within 5 years, n (%)

1 (7)

1 (14)

1

0

–

Blood pressure systole/diastole, mmHg

137 [34]/78 [17]

120 [15]/73 [5]

0.321/0.206

127 [10]/77 [3]

0.608/0.435

Diabetes, n (%)

1 (7)

1 (14)

1.0

0

–

Beta blocker, n (%)

14 (93)

6 (86)

1.0

0

–

ACEi or ARB, n (%)

15 (100)

7 (100)

1.0

0

–

Platelet inhibitor, n (%)

4 (27)

4 (57)

0.343

0

–

Diuretics, n (%)

6 (40)

4 (57)

0.652

0

–

Lipid-lowering drug, n (%)

6 (40)

6 (86)

0.074

0

–

Heart rate, bpm

66 [14]

62 [11]

0.179

65 [16]

0.774

LV EDV, ml

286 [130]

348 [78]

0.448

158 [31]

–

LV EDVi, ml/m²

156 [80]

156 [39]

0.731

87 [6]

–

LV ESV, ml

197 [87]

238 [77]

0.783

68 [11]

–

LV ESVi, ml/m²

106 [50]

115 [45]

0.891

36 [5]

–

LV SV, ml

77 [24]

96 [30]

0.162

91 [24]

0.420

LV SVi, ml/m²

39 [15]

47 [12]

0.407

49 [6]

0.170

LV EF, %

28 [9]

31 [9]

0.630

57 [2]

–

CO, l/min

5.1 [1.5]

5.1 [1.9]

0.837

5.3 [1.0]

0.696

CI, l/min/m²

2.7 [0.75]

2.6 [0.73]

1.0

2.9 [0.56]

0.185

LGE positive, n (%)

11 (73)

6 (86)

1.0

–

–

LGE mean % extent/transmurality

31/42

44/52

0.334/0.360

–

–

LGE positive in septal segments (2, 3, 8, 9 or 14), n (%)

5 (33)

4 (57)

0.376

–

–